Skip to main content
. 2017 Nov 16;17:722. doi: 10.1186/s12879-017-2820-z

Fig. 2.

Fig. 2

Pooled SVR12 rates for 8 regimens – clinical trials. CI, confidence interval; DCV, daclatasvir; EBR, elbasvir; GLE, glecaprevir; GZR, grazoprevir; I-Sq, I2; LDV, ledipasvir; OBV, ombitasvir; Peg-IFN, pegylated interferon; PIB, pibrentasvir; PTV, paritaprevir; RBV, ribavirin; r, ritonavir; SOF, sofosbuvir, RZR, ruzasvir; VEL100, velpatasvir 100 mg; VOX, voxilaprevir. An I2 value of 0% indicates no observed heterogeneity; a dash (−) indicates where data are from a single study